Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 12: 768541, 2021.
Article in English | MEDLINE | ID: mdl-34804056

ABSTRACT

An important challenge for primary or secondary analysis of cytometry data is how to facilitate productive collaboration between domain and quantitative experts. Domain experts in cytometry laboratories and core facilities increasingly recognize the need for automated workflows in the face of increasing data complexity, but by and large, still conduct all analysis using traditional applications, predominantly FlowJo. To a large extent, this cuts domain experts off from the rapidly growing library of Single Cell Data Science algorithms available, curtailing the potential contributions of these experts to the validation and interpretation of results. To address this challenge, we developed FlowKit, a Gating-ML 2.0-compliant Python package that can read and write FCS files and FlowJo workspaces. We present examples of the use of FlowKit for constructing reporting and analysis workflows, including round-tripping results to and from FlowJo for joint analysis by both domain and quantitative experts.


Subject(s)
Flow Cytometry/methods , Software , Workflow , Algorithms , Computational Biology , Humans , Machine Learning , Single-Cell Analysis
2.
Biochemistry ; 47(25): 6662-70, 2008 Jun 24.
Article in English | MEDLINE | ID: mdl-18507398

ABSTRACT

Enfuvirtide (ENF), the first human immunodeficiency virus type 1 (HIV-1) fusion inhibitor approved for clinical use, acts by binding to gp41 heptad repeat 1 (HR1) and preventing its interaction with the viral HR2 region. Treatment-emergent resistance to ENF has been mapped to residues within HR1, and these mutations decrease its susceptibility to ENF and may reduce viral fitness and pathogenesis, although the mechanism for these effects is not clear. N43D, a common ENF resistance mutation, was found in in vitro assays to cause a 5-50-fold in antiviral activity. We introduced this mutation into peptide models and determined the impact of this mutation by circular dichroism and X-ray crystallography. We find that the mutation results in a decrease in the thermal stability of the six-helix bundle and causes a significant change in the HR1-HR2 interface, including a loss of HR2 helicity. These data form a mechanistic basis for the decrease in ENF sensitivity and six-helix bundle stability. The E137K polymorphism, generally present at baseline in patients who develop N43D, partially compensates for the loss of stability, and we show that these residues likely form an ion pair. These data form a framework for understanding the impact of resistance mutations on viral fitness and pathogenesis and provide a pathway for the development of novel fusion inhibitor peptides.


Subject(s)
Drug Resistance, Viral/genetics , HIV Envelope Protein gp41/pharmacology , HIV-1/drug effects , Peptide Fragments/pharmacology , Binding Sites , Circular Dichroism , Crystallography, X-Ray , Enfuvirtide , HIV Envelope Protein gp41/chemistry , HIV Envelope Protein gp41/genetics , HIV Fusion Inhibitors/pharmacology , HIV-1/genetics , Humans , Hydrogen Bonding , Inhibitory Concentration 50 , Models, Molecular , Mutation , Polymorphism, Genetic , Protein Structure, Secondary , Protein Structure, Tertiary
SELECTION OF CITATIONS
SEARCH DETAIL